Detalhe da pesquisa
1.
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.
N Engl J Med
; 387(18): 1649-1660, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36322844
2.
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults.
Blood
; 141(17): 2075-2084, 2023 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564047
3.
Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis.
Blood
; 140(10): 1086-1093, 2022 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35763667
4.
Incorporating radiation with anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approach.
Am J Hematol
; 99(1): 124-134, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37950857
5.
Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study.
Br J Haematol
; 201(6): 1192-1199, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922022
6.
Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma.
Haematologica
; 108(11): 2982-2992, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37317888
7.
Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma.
Pediatr Blood Cancer
; 70 Suppl 6: e30580, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37505794
8.
Prognostic value of chest x-ray- and CT-defined large mediastinal adenopathy in high-risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831.
Pediatr Blood Cancer
; 70(8): e30452, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243975
9.
Children's Oncology Group's 2023 blueprint for research: Radiation oncology.
Pediatr Blood Cancer
; 70 Suppl 6: e30593, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37486145
10.
Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: a Brief Report.
J Cancer Educ
; 38(1): 201-205, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34601699
11.
Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG.
Blood
; 135(26): 2365-2374, 2020 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32211877
12.
Heterogeneity in Radiotherapeutic Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Cancer: A Call for Uniformity.
Value Health
; 25(2): 171-177, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094789
13.
Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancer.
Acta Oncol
; 61(4): 468-477, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965846
14.
Pediatric Hodgkin Lymphoma, Version 3.2021.
J Natl Compr Canc Netw
; 19(6): 733-754, 2021 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34214968
15.
Pulmonary dose tolerance in hemithorax radiotherapy for Ewing sarcoma of the chest wall: Are we overestimating the risk of radiation pneumonitis?
Pediatr Blood Cancer
; 68(11): e29287, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34398486
16.
Second tumor risk in children treated with proton therapy.
Pediatr Blood Cancer
; 68(7): e28941, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33565257
17.
Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031.
Pediatr Blood Cancer
; 68(9): e29212, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34245210
18.
Carbon ion radiation therapy in breast cancer: a new frontier.
Breast Cancer Res Treat
; 181(2): 291-296, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32318954
19.
Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines.
Blood
; 132(16): 1635-1646, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30108066
20.
Expert consensus statements for Waldeyer's ring involvement in pediatric Hodgkin lymphoma: The staging, evaluation, and response criteria harmonization (SEARCH) for childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL) group.
Pediatr Blood Cancer
; 67(9): e28361, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32672879